Patients | Anti-PCNA after absorption with PCNA (OD) | Per cent binding inhibition | |||||
---|---|---|---|---|---|---|---|
0 μg | 0.1 μg | 0.5 μg | 1 μg | 3 μg | 6 μg | ||
HBV | |||||||
8 | 1.473 | 0.953 | 0.547 | 0.629 | 0.423 | 0.499 | 71.3 |
50 | 2.290 | 1.546 | 0.498 | 1.043 | 0.470 | 0.658 | 79.5 |
51 | 3.142 | 1.393 | 0.699 | 1.462 | 1.011 | 0.514 | 77.8 |
103 | 3.151 | 0.873 | 0.604 | 0.880 | 0.759 | 0 | 80.8 |
113 | 4.100 | 1.651 | 1.437 | 1.936 | 1.229 | 0.395 | 90.4 |
HCV | |||||||
46 | 2.082 | 1.349 | 1.427 | 1.112 | 0.751 | 0.322 | 84.5 |
55 | 3.233 | 2.896 | 1.292 | 2.375 | 1.955 | 0.607 | 81.7 |
78 | 1.798 | 0.985 | 0.158 | 0.355 | 0.458 | 0.193 | 89.3 |
SLE | 3.729 | 2.914 | 1.668 | 1.672 | 1.096 | 0.858 | 77.0 |